Talal El Zarif - Concepedia

Author

Talal El Zarif

Also Known As

Amin H Nassar, Heather A Wakelee, Herrera, Alex F, Ravi, Praful, T El Zarif, T. El Zarif, Talal El Zarif, Talal El‐Zarif

269

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital Harvard University Icahn School of Medicine at Mount Sinai University of California San Diego

About

Talal El Zarif is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	476
2	Health Sciences	2	2	128
3	Public Health	1	1	31
4	Cell Biology	1	1	32
5	Endocrinology	1	1	19

Talal El Zarif

Publications

Citations

H-Index

Page 1

	Year	Citations
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors Amin H. Nassar, Elio Adib, Sarah Abou Alaiwi, Cancer Cell Tumor Mutational BurdenCancer ImmunosurveillanceTumor HeterogeneityMedicineImmunology	2022	109
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium Ziad Bakouny, Talal El Zarif, Shaan Dudani, European Urology Surgical OncologyUpfront Cytoreductive NephrectomyUrologyGenitourinary CancerMedicine	2022	103
Germline variants associated with toxicity to immune checkpoint blockade Stefan Groha, Sarah Abou Alaiwi, Wenxin Xu, Nature Medicine ImmunogeneticsImmunologyPathologyImmune Checkpoint InhibitorInborn Error Of Immunity	2022	99
COVID-19 vaccination and breakthrough infections in patients with cancer Andrew Schmidt, Chris Labaki, Chih–Yuan Hsu, Annals of Oncology	2021	98
Liquid biopsy epigenomic profiling for cancer subtyping Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Nature Medicine	2023	97
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium Talal El Zarif, Amin H. Nassar, Elio Adib, Journal of Clinical Oncology	2023	55
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors Talal El Zarif, Amin H. Nassar, Gregory R. Pond, JNCI Journal of the National Cancer Institute	2023	49
Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance Donjeta Gjuka, Elio Adib, Kendra Garrison, Cancer Cell Mtap-deficient TumorsRadiation OncologyCancer ImmunosurveillanceT-regulatory CellImmunology	2023	46
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response Jacob E. Berchuck, Elio Adib, Sarah Abou Alaiwi, Cancer Research	2022	38
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer Elio Adib, Talal El Zarif, Amin H. Nassar, British Journal of Cancer	2021	33

Page 1